STING Drives CD4 + T Cell Differentiation via JAK – STAT Signalling in Bullous Pemphigoid
Experimental Dermatology · 2026-07 · 35 (7)
DOI: 10.1111/exd.70328 ↗At a glance
Journal article in Experimental Dermatology, published online on 2026-07-17. Written by Weiwei Jiang and 5 co-authors. Institution: Department of Dermatology, Tianjin Institute of Integrative Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin…. Major MEDLINE topics: CD4-Positive T-Lymphocytes, Membrane Proteins, Pemphigoid, Bullous, Janus Kinase 1. 26 references. The full text is freely available in PubMed Central. Funded by: Tianjin Key Medical Discipline Construction (Grant No. TJYXZDXK-3-027C), National Natural Science Foundation of China.
Abstract (original language)
Bullous pemphigoid (BP) is an autoimmune blistering disease with an increasing incidence in recent years; however, the underlying immune regulatory mechanisms remain largely unclear. As a critical signalling hub linking innate and adaptive immunity, stimulator of interferon genes (STING) has recently been implicated in the pathogenesis of various autoimmune diseases and may regulate tissue inflammation and immune homeostasis through modulation of CD4 + T cell responses. In this study, we found that STING expression was significantly increased in lesional skin tissues from patients with BP compared with healthy controls. Transcriptomic analysis further revealed that differentially expressed genes in peripheral blood CD4 + T cells from BP patients were primarily enriched in the JAK–STAT signalling pathway, T cell activation and differentiation, and type I interferon (IFN‐I)‐related pathways. Pharmacological inhibition of STING markedly attenuated the aberrant activation of these signalling pathways. Moreover, qRT‐PCR analysis confirmed that the mRNA levels of STING1, JAK1, and CXCR5 were significantly elevated in BP patients, whereas treatment with the STING inhibitor C176 suppressed the expression of these molecules. Collectively, our findings suggest that STING may contribute to BP immunopathogenesis by regulating the JAK–STAT signalling axis and promoting abnormal CD4 + T cell activation and differentiation, providing new insights into the molecular mechanisms underlying BP and identifying potential therapeutic targets.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Dermatology, Tianjin Institute of Integrative Dermatology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China.
- State Key Laboratory of Chinese Medicine Modernization, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
- Immunology Department, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Tianjin Medical University, Tianjin, China.
ORCID profiles: Weiwei Jiang, Mengke Sun, Junchen He, Lizhi Hu
Funding
- Tianjin Key Medical Discipline Construction (Grant No. TJYXZDXK-3-027C)
- National Natural Science Foundation of China
Cite
APA
Jiang, W., Sun, M., He, J., Wang, T., Guo, T., & Hu, L. (2026). STING Drives CD4 + T Cell Differentiation via JAK – STAT Signalling in Bullous Pemphigoid. Experimental Dermatology, 35(7). https://doi.org/10.1111/exd.70328
Vancouver
Jiang W, Sun M, He J, Wang T, Guo T, Hu L. STING Drives CD4 + T Cell Differentiation via JAK – STAT Signalling in Bullous Pemphigoid. Experimental Dermatology. 2026;35(7). doi:10.1111/exd.70328
BibTeX
@article{Jiang2026,
author = {Jiang, Weiwei and Sun, Mengke and He, Junchen and Wang, Tianxue and Guo, Tao and Hu, Lizhi},
title = {STING Drives CD4 + T Cell Differentiation via JAK – STAT Signalling in Bullous Pemphigoid},
journal = {Experimental Dermatology},
year = {2026},
volume = {35},
number = {7},
doi = {10.1111/exd.70328}
}
EUVIMED